Español

Authors

  • Español
  • Español
  • Español

Keywords:

Español

Abstract

On analyse the Spanish pharmaceutical market offer to cover the,. gastroesofagic reflux disease (GERD) therapy in paediatric population. A review of the pharmaceutical specialities corresponding to the groups A03AF, A02BA, and A02BC from the Specialities Catalogue of the Pharmaceutical College General Council attending to: Paediatric dosage and Pharmaceutical form this drugs are presento In the 44 % drugs in volved in GERD therapy specific paediatric studies aren't fit for use. The 33% of AH2 and 40% of IBP are usable in children. Any IBP has a correctly design presentation for paediatric population. On conclude that actual market hasn't correctly design medicines of the more effective therapies in the GERD treatment.

Downloads

Published

2003-12-20

How to Cite

1.
Español, Español, Español. Español. Ars Pharm [Internet]. 2003 Dec. 20 [cited 2025 Jun. 4];45(1):73-80. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/24723

Issue

Section

Special Articles